ProMIS Neurosciences Inc
NASDAQ:PMN
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
ProMIS Neurosciences Inc
NASDAQ:PMN
|
CA |
|
C
|
Cohen & Steers Inc
F:FG9
|
US |
|
A
|
Actic Group AB
F:8XA
|
SE |
|
T
|
TJX Companies Inc
DUS:TJX
|
US |
|
Theon International Plc
F:W8C
|
CY |
|
Aviva PLC
LSE:AV
|
UK |
|
Rheinmetall AG
OTC:RNMBF
|
DE |
|
US Foods Holding Corp
NYSE:USFD
|
US |
|
Dianomi PLC
LSE:DNM
|
UK |
|
Mcphy Energy SA
OTC:MPHYF
|
FR |
|
M
|
Microchip Technology Inc
XETRA:MCP
|
US |
|
S
|
Sumitomo Osaka Cement Co Ltd
XBER:SU2
|
JP |
|
Home Depot Inc
NYSE:HD
|
US |
|
G
|
Grenke AG
XBER:GLJ
|
DE |
|
NK Lukoil PAO
MOEX:LKOH
|
RU |
|
E
|
Edgewell Personal Care Co
XMUN:EGZ
|
US |
|
Talga Group Ltd
ASX:TLG
|
AU |
|
P
|
Prudential PLC
DUS:PRU
|
UK |
|
PPC Ltd
OTC:PPCLY
|
ZA |
|
MMP Industries Ltd
NSE:MMP
|
IN |
|
N
|
Nextera Energy Partners LP
F:1N6
|
US |
|
B
|
Budweiser Brewing Company APAC Ltd
OTC:BDWBF
|
HK |
Bankruptcy Probability
ProMIS Neurosciences Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
ProMIS Neurosciences Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| CA |
|
ProMIS Neurosciences Inc
TSX:PMN
|
51.5m CAD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
443.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
208B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
161.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
121.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
80.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
45.2B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
ProMIS Neurosciences Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, ProMIS Neurosciences Inc has no debt.
You can find a full breakdown on its Balance Sheet.
